(ANIP) |
| 0 (0%) 10-10 16:16 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 99.50 |
| Resistance 1: | 95.17 |
| Pivot price: | 92.09 |
| Support 1: | 88.16 |
| Support 2: | 73.35 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.690 |
| Book Value | 21.700 |
| PEG Ratio | 0.00 |
| Gross Profit | 20.475 |
| Profit Margin (%) | -1.37 |
| Operating Margin (%) | 7.18 |
| Return on Assets (ttm) | 1.1 |
| Return on Equity (ttm) | -2.2 |
Company news
Fri, 10 Oct 2025
3 Reasons Why Growth Investors Shouldn't Overlook ANI (ANIP) - Nasdaq
Fri, 10 Oct 2025
Truist Financial Issues Positive Forecast for ANI Pharmaceuticals (NASDAQ:ANIP) Stock Price - MarketBeat
Fri, 10 Oct 2025
Are Medical Stocks Lagging ANI Pharmaceuticals (ANIP) This Year? - Yahoo Finance
Thu, 09 Oct 2025
New Analyst Forecast: $ANIP Given 'Hold' Rating - Quiver Quantitative
Wed, 08 Oct 2025
ANI Pharmaceuticals (NASDAQ:ANIP) Downgraded to "Sell (D+)" Rating by Weiss Ratings - MarketBeat
Tue, 07 Oct 2025
ANI Pharmaceuticals (ANIP): Buy, Sell, Or Hold Post Q2 Earnings? - Barchart.com
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
